Phase 1 - The three most innovative business ideas!
54 teams from 15 countries and 3 continents contested in phase 1 of the competition - a strong signal for the innovative and entrepreneurial power in the life sciences! 14 projects belonged to Medical Technology, 22 to Red Biotechnology, 6 to Supply, 4 to Diagnostics, 3 to Food, 2 to White Biotech, 2 to Bioinformatics and 1 to Green Biotech.
38 BOB evaluators from 6 countries performed a total of 216 evaluations providing detailed feedback to the participants.
On May 10th, 2012, the three winning teams were presented to the public and awarded a cash prize of € 1,500 each at a ceremony held in the premises of Austria Wirtschaftsservice. Find below a short presentation of the winning teams in alphabetical order.
Genequine Biotherapeutics
Kilian GUSE
Development of Biotechnological Drugs for Veterinary Diseases with Large Unmet Medical Needs.
SIMCharacters
Jens SCHWINDT, Christoph KUNZMANN, Michael HOFFMANN
The SIMCharacters Team breaks new ground in the development of small training simulators and combines know- how in the medical area, lifelike anatomy and high-class animation technology.
ViraTherapeutics
Dorothee VON LAER, Lisa EGERER, Sabrina MAROZIN
ViraTherapeutics develops innovative virus –based medicines for the treatment of cancer patients, including those for whom conventional therapy has failed.
Phase 1 Evaluators
38 BOB evaluators from 6 countries performed a total of 216 evaluations providing detailed feedback to the participants.
Impressions from the BOB Award Ceremony
Key Note Speech by Dr. Rainer Marksteiner / CSO and Co-Founder Innovacell Biotechnologie AG
"From university to business"
Reception in honor of the 3 winners and all BOB Alumni.





_ssml.jpg)
_ssml.jpg)


























